FDA inspection
PharmaEssentia Corporation, Taichung Plant: FDA inspection ending Apr 18, 2023
FDA inspection 1204044 · Voluntary Action Indicated (VAI) · Taichung
Key facts
| Inspection ID | 1204044 |
|---|---|
| Firm | PharmaEssentia Corporation, Taichung Plant |
| FEI number | 2000012832 |
| Address | No. 28 Daya Dist, 3 F; Keya West Rd. |
| City | Taichung |
| Country | Taiwan |
| Fiscal year | 2023 |
| Inspection end date | Apr 18, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data